Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction
What this study shows
Genome-wide CRISPR screens reveal AMPK and HRI relay mitochondrial dysfunction to mTORC1.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: CRISPR screen; cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | CRISPR screen; cells |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Year | 2021 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1073/pnas.2022120118 · PMID 33483422 · Free full text (PMC7848693) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genome-wide CRISPR-Cas9 screen |
| Target | mTORC1 (mitochondrial-dysfunction sensing) |
| Model | CRISPR screen; cells |
| Effect | CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction |
In the Atlas
Related topics
Links in the pathway map
Was this page useful?
Thank you. Your answer was counted anonymously.